NanoBiT Complementation to Monitor Agonist-Induced Adenosine A
GPCR
NanoBiT
adenosine
nanoluciferase complementation
receptor internalization
Journal
SLAS discovery : advancing life sciences R & D
ISSN: 2472-5560
Titre abrégé: SLAS Discov
Pays: United States
ID NLM: 101697563
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
pubmed:
5
10
2019
medline:
17
7
2021
entrez:
5
10
2019
Statut:
ppublish
Résumé
Receptor internalization in response to prolonged agonist treatment is an important regulator of G protein-coupled receptor (GPCR) function. The adenosine A
Identifiants
pubmed: 31583945
doi: 10.1177/2472555219880475
pmc: PMC6974774
pii: S2472-5552(22)06532-7
doi:
Substances chimiques
Adenosine A1 Receptor Agonists
0
Ligands
0
Receptor, Adenosine A1
0
Receptors, G-Protein-Coupled
0
Xanthines
0
1,3-dipropyl-8-cyclopentylxanthine
9PTP4FOI9E
Adenosine
K72T3FS567
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
186-194Subventions
Organisme : Medical Research Council
ID : MR/N020081/1
Pays : United Kingdom
Références
Mol Pharmacol. 1997 Nov;52(5):788-97
pubmed: 9351969
Annu Rev Biochem. 1998;67:653-92
pubmed: 9759500
Biochemistry. 2002 Dec 17;41(50):14748-61
pubmed: 12475223
Clin Res Cardiol. 2012 Jul;101(7):585-91
pubmed: 22370739
ACS Chem Biol. 2016 Feb 19;11(2):400-8
pubmed: 26569370
Purinergic Signal. 2012 Feb;8(Suppl 1):91-9
pubmed: 22081230
Biochem Pharmacol. 2016 Jan 1;99:101-12
pubmed: 26581123
Neurochem Res. 1998 Feb;23(2):211-8
pubmed: 9475516
Pharmacol Rev. 2011 Mar;63(1):1-34
pubmed: 21303899
Exp Cell Res. 2003 Apr 15;285(1):72-90
pubmed: 12681288
Bioorg Med Chem. 2006 Apr 15;14(8):2837-49
pubmed: 16377196
Biochem Pharmacol. 2018 Jan;147:55-66
pubmed: 29106905
Purinergic Signal. 2015 Sep;11(3):389-407
pubmed: 26126429
J Biol Chem. 2016 Apr 22;291(17):8969-77
pubmed: 26984408
Nat Rev Mol Cell Biol. 2002 Sep;3(9):639-50
pubmed: 12209124
Biochem Pharmacol. 2018 Feb;148:298-307
pubmed: 29309765
Eur J Pharmacol. 2011 Nov 30;670(2-3):365-71
pubmed: 21946103
Curr Opin Cell Biol. 2014 Apr;27:109-16
pubmed: 24680436
Nat Methods. 2015 Jul;12(7):661-663
pubmed: 26030448
Biochim Biophys Acta. 2011 May;1808(5):1319-28
pubmed: 20550943
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3712-7
pubmed: 10097102
Br J Pharmacol. 2014 Aug;171(16):3827-44
pubmed: 24750014
Trends Endocrinol Metab. 2017 Mar;28(3):213-226
pubmed: 27889227
Biotechniques. 2018 Jul;65(1):9-14
pubmed: 30014734
J Biol Chem. 1998 Jul 10;273(28):17610-7
pubmed: 9651356
Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):83-91
pubmed: 29678288
Eur J Pharmacol. 2005 Oct 17;522(1-3):1-8
pubmed: 16214128
J Biol Chem. 2018 May 11;293(19):7466-7473
pubmed: 29523687
Mol Pharmacol. 2000 Sep;58(3):477-82
pubmed: 10953039
Br J Pharmacol. 2004 Nov;143(6):705-14
pubmed: 15302686
Nature. 2018 Jun;558(7711):559-563
pubmed: 29925945
Purinergic Signal. 2008 Mar;4(1):21-37
pubmed: 18368531
Mol Pharmacol. 2001 May;59(5):1314-23
pubmed: 11306717
ACS Chem Biol. 2012 Nov 16;7(11):1848-57
pubmed: 22894855
J Neurochem. 2000 Oct;75(4):1493-501
pubmed: 10987829
J Biol Chem. 2019 Mar 15;294(11):4079-4090
pubmed: 30593506
Br J Pharmacol. 2017 Dec;174 Suppl 1:S17-S129
pubmed: 29055040
ACS Chem Biol. 2018 Feb 16;13(2):467-474
pubmed: 28892606
Sci Rep. 2018 Jan 25;8(1):1572
pubmed: 29371669
Mol Pharmacol. 1997 Sep;52(3):456-64
pubmed: 9281608
Br J Pharmacol. 2019 Apr;176(7):864-878
pubmed: 30644086
ACS Chem Biol. 2018 Sep 21;13(9):2758-2770
pubmed: 30137962